Navigation Links
Lafley Tells Shareholders That 'P&G is Designed to Grow'
Date:10/9/2007

5 %

Free Cash Flow. Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.

Free Cash Flow Productivity. Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The company's long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below ($ millions):

Operating Capital Free Net Free Cash

Cash Spending Cash Earnings Flow

Flow Flow Productivity

Fiscal $13,435 $(2,945) $10,490 $10,340 101 %

2007


'/>"/>
SOURCE The Procter & Gamble Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
2. Gene variant foretells diabetic neuropathy
3. China tells officials not to hide SARS damage
4. Speed up bird flu vaccine, Bush tells experts
5. Life Beyond Cancer - Delhi Woman Tells How
6. Bush Tells Seniors Drug Plan Is A Good Deal
7. Consider Euthanasia For Severely Disabled Babies, College Tells Doctors
8. Tamiflu: Adverse Reaction Warning, ‘a Must’, Canada Tells Roce
9. Own Up and Pay Up, Nigerian Party Tells Pfizer
10. Steve Tyler Tells All About His Beauty Regime
11. Subsidize Solar Water Heaters for Homes, Expert Tells Australian Government
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2St Jude Childrens Research Hospital 28R 29 Chilis 28R 29 Grill 26 Bar Kick off Sixth Annual Create A Pepper to Fight Childhood Cancer Campaign 55537 1St Jude Childrens Research Hospital 28R 29 Chilis 28R 29 Grill 26 Bar Kick off Sixth Annual Create A Pepper to Fight Childhood Cancer Campaign 55537 2St Jude Childrens Research Hospital 28R 29 Chilis 28R 29 Grill 26 Bar Kick off Sixth Annual Create A Pepper to Fight Childhood Cancer Campaign 55537 3Joint Commission Alert 3A Effective Leadership Critical to Preventing Medical Errors 55534 1Joint Commission Alert 3A Effective Leadership Critical to Preventing Medical Errors 55534 2Joint Commission Alert 3A Effective Leadership Critical to Preventing Medical Errors 55534 3Caraco Pharmaceutical Laboratories Ltd Announces Reversal of Summary Judgment in Ultracet 28R 29 ANDA Patent Litigation 55531 1Caraco Pharmaceutical Laboratories Ltd Announces Reversal of Summary Judgment in Ultracet 28R 29 ANDA Patent Litigation 55531 2